Pharmarise Holdings Corporation (TYO:2796)

Pharmarise Holdings Revenue

Pharmarise Holdings had revenue of 17.24B JPY in the quarter ending August 31, 2026, with 2.92% growth. This brings the company's total for the last twelve months to 70.00B, up 7.64% year-over-year. In the fiscal year ending May 31, 2026, Pharmarise Holdings had annual revenue of 69.51B with 9.45% growth. That makes Pharmarise Holdings the 11,886th largest company in the world by revenue and 1,238th in Japan.

• Revenue (ttm): 70.00B
• Revenue Growth: +7.64%
• P/S Ratio: 0.08
• Revenue / Employee: 34.47M
• Employees: 2,031
• Market Cap: 5.82B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Dispensing Pharmacy 59.33B 85.4%
• Drug/Convenience Store 8.04B 11.6%
• Other 986.00M 1.4%
• Storage and Management of Medical Documents 647.00M 0.9%
• Medical Mall Management 505.00M 0.7%

Fiscal year ended May 31, 2026 See the full Pharmarise Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2026	69.51B	6.00B	9.45%
May 31, 2025	63.51B	9.04B	16.60%
May 31, 2024	54.47B	2.44B	4.68%
May 31, 2023	52.03B	422.00M	0.82%
May 31, 2022	51.61B	-716.00M	-1.37%

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error